- info@ezadeh.com
- 27-31 Wright St, Clayton VIC 3168
- Contact
24May
Weight loss linked to nerve cells in the brain
by Elazadeh, 0 Comments
Credit: Cell Metabolism (2025). DOI: 10.1016/j.cmet.2025.04.018 Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown to effectively reduce food intake and body weight. The drug […]
23May
Potential new drug that protects blood-brain barrier shows promise against Alzheimer’s
by Elazadeh, 0 Comments
Brain 15-PGDH increases in human and mouse AD, TBI, and aging and is enriched in brain myeloid cells. Credit: Proceedings of the National Academy of Sciences (2025). DOI: 10.1073/pnas.2417224122 Worldwide, […]
20May
Human-specific DNA enhancer linked to brain development and neuron proliferation
by Elazadeh, 0 Comments
Correlation analysis of resting state activity of each individual mouse. Credit: Nature (2025). DOI: 10.1038/s41586-025-09002-1 Duke University Medical Center-led research has identified a human-specific DNA enhancer that regulates neural progenitor […]
09May
Unique model of rare epileptic disease helps pinpoint potential treatment route
by Elazadeh, 0 Comments
Credit: Pixabay/CC0 Public Domain While extremely rare, encephalopathy (a condition affecting brain function) triggered by mutations in the UBA5 gene has devastating impacts, with affected individuals reaching few developmental milestones […]
03May
N-cadherin triggers neural stem cell differentiation: Discovery shows potential for brain aging and disease therapies
by Elazadeh, 0 Comments
Neural stem cells can develop into various types of neurons and non-neuronal cells but with aging they don’t differentiate as easily. Credit: Matthew Modoono/Northeastern University Northeastern University scientists have discovered […]
03May
Editing Parkinson’s disease—discovery of an inflammatory RNA editing enzyme
by Elazadeh, 0 Comments
Schematic diagram of the inflammatory RNA editing model in Parkinson’s disease. Credit: Science Advances (2025). DOI: 10.1126/sciadv.adp8504 Parkinson’s disease (PD) is a neurodegenerative disorder in which the α-synuclein protein abnormally […]